These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 222873

  • 1. Role of aldosterone in experimental hypertension.
    McCaa RE, McCaa CS, Bengis RG, Guyton AC.
    J Endocrinol; 1979 May; 81(2):69P-78P. PubMed ID: 222873
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H, Uneda S, Tochikubo O, Ohonishi T, Harada J, Sesoko S, Goto E, Fujishima S, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract] [Full Text] [Related]

  • 3. Role of the renin-angiotensin-aldosterone system in the regulation of blood pressure.
    Barger AC.
    Adv Nephrol Necker Hosp; 1980 Jan; 9():271-93. PubMed ID: 6250379
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A, Caralps A, Rama H, Sarrias X, Alsina J.
    Rev Clin Esp; 1981 Sep 30; 162(6):265-8. PubMed ID: 7036249
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renin-angiotensin system in an infant with malignant renovascular hypertension.
    Fyhrquist F, Kuitunen P, Kojo N.
    Helv Paediatr Acta; 1976 Jun 30; 31(1):61-5. PubMed ID: 939701
    [Abstract] [Full Text] [Related]

  • 9. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May 30; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 10. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.
    Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, Vukovich RA.
    N Engl J Med; 1974 Oct 17; 291(16):817-21. PubMed ID: 4371298
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Humoral effects of the oral converting-enzyme inhibitor SQ 14,225 in hypertensive patients in supine and tilted position.
    Morganti A, Pickering TG, Lopez-Ovejero J, Laragh JH.
    Clin Sci (Lond); 1979 Dec 17; 57 Suppl 5():149s-152s. PubMed ID: 232018
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB, Atlas SA, Laragh JH.
    Clin Sci (Lond); 1979 Dec 17; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [Abstract] [Full Text] [Related]

  • 18. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF, Laragh JH.
    Urol Clin North Am; 1975 Jun 17; 2(2):237-57. PubMed ID: 1098253
    [Abstract] [Full Text] [Related]

  • 19. Studies of plasma renin activity in patients with hypertension.
    Kokot F, Kuska J, Czekala Z, Kiecoń I.
    Pol Med J; 1968 Jun 17; 7(6):1319-27. PubMed ID: 4305122
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.